440 results on '"Jang, Tae-Won"'
Search Results
2. Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database
3. Association between social jetlag and self-rated health: Evidence from Korean representative working population
4. Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure
5. Recommendation of pharmacokinetics/pharmacodynamics target of ethambutol to suppress tuberculosis resistance: A population pharmacokinetics study on a large prospective cohort
6. Social jetlag and risk of depression: Results from the Korea National Health and Nutrition Examination Survey
7. Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence
8. Investigating treatment response and immune profile in association with pattern identification in NSCLC patients scheduled for immune checkpoint inhibitor monotherapy (HARMONY study): A protocol for a prospective observational study
9. The relationship between the pattern of shift work and sleep disturbances in Korean firefighters
10. The Fourth Industrial Revolution and Its Impact on Occupational Health and Safety, Worker's Compensation and Labor Conditions
11. Sleep Assessment During Shift Work in Korean Firefighters: A Cross-Sectional Study
12. Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis
13. Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea
14. Trend of prevalence and characteristics of preserved ratio impaired spirometry (PRISm): Nationwide population-based survey between 2010 and 2019.
15. Association between social jetlag and self-rated health: Evidence from Korean representative working population
16. Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
17. Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non–Small Cell Lung Cancer: Updated Analysis of the RESET Study
18. Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non–Small-cell Lung Cancer: A TRAIL Trial
19. Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
20. Recommendation of Pharmacokinetics/Pharmacodynamics Target of Ethambutol to Suppress Tuberculosis Resistance: A Population Pharmacokinetics Study on Large Prospective Cohort
21. Abstract 3886: Analysis of concomitant genetic alterations in advanced EGFR-mutated lung adenocarcinoma by targeted NGS: A multicenter prospective and real world study
22. The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea
23. Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
24. Development of algorithm for work intensity evaluation using excess overwork index of construction workers with real-time heart rate measurement device
25. Special Series I: Working hours as a social determinant of workers’ health
26. Working hours and the regulations for night shift workers
27. Pulmonary Hypertension With Unilateral Pulmonary Vein Atresia
28. Protective effects of Camellia sinensis fruit and fruit peels against oxidative DNA damage
29. Clinical characteristics of non-small cell lung cancer patients who experienced acquired resistance during gefitinib treatment
30. Improved Adaptive Modulation and Coding of MIMO with Selection Transmit Diversity Systems
31. Nypa fruticans Wurmb inhibits melanogenesis in isobutylmethylxanthine‑treated melanoma via the PI3K/AKT/mTOR/CREB and MAPK signaling pathways
32. Application of several machine learning algorithms for the prediction of afatinib treatment outcome in advanced‐stage EGFR ‐mutated non‐small‐cell lung cancer
33. A phase II , multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable,EGFRmutation‐positive non‐small cell lung cancer (stage III ) who have not progressed following definitive, platinum‐based, chemoradiation therapy ( PLATINUM trial)
34. Beneficial role of Boehmeria nivea in health and phytochemical constituents
35. Comparison of the bioactive compounds and anti-inflammatory effects found in different flower colors fromAbeliophyllum distichumNakai
36. Performance Limitation of STBC OFDM-CDMA Systems in Mobile Fading Channels
37. Paclitaxel-Loaded Polymeric Micelle (230 mg/m2) and Cisplatin (60 mg/m2) vs. Paclitaxel (175 mg/m2) and Cisplatin (60 mg/m2) in Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase IIB Trial
38. Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer
39. Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial
40. Clinical outcomes of hyperprogression based on volumetry in non‐small cell lung cancer after immune checkpoint inhibitor treatment
41. The standards for recognition of occupational cancers related with polycyclic aromatic hydrocarbons (PAHs) in Korea
42. First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea
43. Association between sleep quality and type of shift work in Korean firefighters
44. Comparative analyses of occupational injuries among temporary agency worker and direct contract workers: Findings from the Korea Health Panel 2009–2018
45. Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer
46. A communicational analysis for mathematical modeling process
47. 论'是时候'的副词化
48. A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (stage III) who have not progressed following definitive, platinum‐based, chemoradiation therapy (PLATINUM trial)
49. Gender-specific influence of socioeconomic status on the prevalence of migraine and tension-type headache: the results from the Korean headache survey
50. Tracheal cartilage regeneration by progenitor cells derived from the perichondrium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.